Literature DB >> 33744992

Low keV portal venous phase as a surrogate for pancreatic phase in a pancreatic protocol dual-energy CT: feasibility, image quality, and lesion conspicuity.

Yoshifumi Noda1,2, Toru Tochigi1,3, Anushri Parakh1, Evita Joseph1, Peter F Hahn1, Avinash Kambadakone4.   

Abstract

OBJECTIVE: To assess the feasibility of a proposed pancreatic protocol CT generated from portal-venous phase (PVP) dual-energy CT (DECT) acquisition and its impact on image quality, lesion conspicuity, and arterial visualization/involvement.
METHODS: We included 111 patients (mean age, 66.8 years) who underwent pancreatic protocol DECT (pancreatic phase, PP, and PVP). The original DECT acquisition was used to create two data sets-standard protocol (50 keV PP/65 keV PVP) and proposed protocol (40 keV/65 keV PVP). Three reviewers evaluated the two data sets for image quality, lesion conspicuity, and arterial visualization/involvement using a 5-point scale. The signal-to-noise ratio (SNR) of pancreas and lesion-to-pancreas contrast-to-noise ratio (CNR) was calculated. Qualitative scores, quantitative parameters, and dose-length product (DLP) were compared between standard and proposed protocols.
RESULTS: The image quality, SNR of pancreas, and lesion-to-pancreas CNR of the standard and proposed protocol were comparable (p = 0.11-1.00). Lesion conspicuity was comparable between the standard and proposed protocols for pancreatic ductal adenocarcinoma (p = 0.55) and pancreatic cysts (p = 0.28). The visualization of larger arteries and arterial involvement were comparable between the two protocols (p = 0.056-1.00) while the scores were higher for smaller vessels in the standard protocol (p < 0.0001-0.0015). DLP of the proposed protocol (670.4 mGy·cm) showed a projected 42% reduction than the standard protocol (1145.9 mGy·cm) (p < 0.0001).
CONCLUSION: Pancreatic protocol CT generated from a single PVP DECT acquisition is feasible and could potentially be an alternative to the standard pancreatic protocol with PP and PVP. KEY POINTS: • The lesion conspicuity for focal pancreatic lesions was comparable between the proposed protocol and standard dual-phase pancreatic protocol CT. • Qualitative and quantitative image assessments were almost comparable between two protocols. • The radiation dose of a proposed protocol showed a projected 42% reduction from the conventional protocol.

Entities:  

Keywords:  Cancer screening; Multidetector-row computed tomography; Pancreatic neoplasms; Radiation dosage

Year:  2021        PMID: 33744992     DOI: 10.1007/s00330-021-07744-w

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  4 in total

1.  Image quality comparison of two adaptive statistical iterative reconstruction (ASiR, ASiR-V) algorithms and filtered back projection in routine liver CT.

Authors:  Li-Hong Chen; Chao Jin; Jian-Ying Li; Ge-Liang Wang; Yong-Jun Jia; Hai-Feng Duan; Ning Pan; Jianxin Guo
Journal:  Br J Radiol       Date:  2018-06-06       Impact factor: 3.039

2.  Split-bolus vs. multiphasic contrast bolus protocol in patients with pancreatic cancer or cholangiocarcinoma.

Authors:  Hanna Muenzfeld; Samy Mahjoub; Robert Roehle; Uwe Pelzer; Marcus Bahra; Georg Boening; Bernd Hamm; Dominik Geisel; Timo Alexander Auer
Journal:  Eur J Radiol       Date:  2019-08-09       Impact factor: 3.528

3.  Retrospective analysis of dual-phase MDCT and follow-up EUS/EUS-FNA in the diagnosis of pancreatic cancer.

Authors:  Eric P Tamm; Evelyne M Loyer; Silvana C Faria; Douglas B Evans; Robert A Wolff; Chusilp Charnsangavej
Journal:  Abdom Imaging       Date:  2007 Sep-Oct

4.  Clinical value of a new generation adaptive statistical iterative reconstruction (ASIR-V) in the diagnosis of pulmonary nodule in low-dose chest CT.

Authors:  Hui Tang; Zhentang Liu; Zhijun Hu; Taiping He; Dou Li; Nan Yu; Yongjun Jia; Hong Shi
Journal:  Br J Radiol       Date:  2019-09-06       Impact factor: 3.039

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.